BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11979832)

  • 1. [Intractable ulcer after the eradication of Helicobacter pylori].
    Taguchi Y; Imoto I
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():483-7. PubMed ID: 11979832
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gastric ulcer is one of the diseases for which Helicobacter pylori eradication is recommended].
    Satoh K
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():259-63. PubMed ID: 16363541
    [No Abstract]   [Full Text] [Related]  

  • 3. Peptic ulcer disease in the elderly.
    Cryer B; Feldman M
    Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.
    Wu CY; Wu MS; Chen CJ; Li MC; Lin JT; Chen GH
    J Clin Gastroenterol; 2005 Jan; 39(1):50-5. PubMed ID: 15599211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Helicobacter pylori infections.
    Thijs JC; Kuipers EJ; van Zwet AA; Pena AS; de Graaff J
    QJM; 1995 Jun; 88(6):369-89. PubMed ID: 7648229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ulcerative disease and dyspepsia--which treatment is proven?].
    Malfertheiner P; Brucks U; Peitz U
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S8-15. PubMed ID: 11450620
    [No Abstract]   [Full Text] [Related]  

  • 8. [The analysis of the recurrence ulcer after H. pylori eradication].
    Kamada T; Chayama K; Haruma K; Yoshihara M; Ito M; Kitadai Y; Kawamura Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():501-5. PubMed ID: 11979837
    [No Abstract]   [Full Text] [Related]  

  • 9. [Helicobacter pylori infection--current status in clinical practice and prospects].
    Malfertheiner P
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():15-9. PubMed ID: 12466998
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for the eradication of Helicobacter pylori. Reflections on the Maastricht consensus conference].
    Boixeda de Miquel D; Martín de Argila C; Pérez Gisbert J
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():29-34. PubMed ID: 9549200
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of reflux esophagitis after H. pylori eradication].
    Koike T; Ohara S; Lijima K; Sekine H; Shimosegawa T
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():495-8. PubMed ID: 16363587
    [No Abstract]   [Full Text] [Related]  

  • 12. [Gastric ulcer and duodenal ulcer (excluding Zollinger-Ellison syndrome). Epidemiology, physiopathology, diagnosis, course, treatment].
    Bigard MA
    Rev Prat; 1999 Mar; 49(5):547-54. PubMed ID: 10358406
    [No Abstract]   [Full Text] [Related]  

  • 13. Helicobacter pylori, gastric ulcer, and agents noxious to the gastric mucosa.
    Laine L
    Gastroenterol Clin North Am; 1993 Mar; 22(1):117-25. PubMed ID: 8449561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of non-steroidal anti-inflammatory drugs on gastric and duodenal prostaglandin concentrations in patients with Helicobacter pylori infection.
    Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Tsay SH; Li AS; Chang FY; Lee SD
    Hepatogastroenterology; 1999; 46(26):1000-4. PubMed ID: 10370655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Helicobacter pylori and the treatment of gastric ulcer. Reflections and uncertainties].
    Dobrilla G; Piazzi L; Amplatz S
    An Med Interna; 1993 Feb; 10(2):91-7. PubMed ID: 8452981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of helicobacteriosis in stomach and duodenal lesions].
    Ostrovskiĭ IM
    Ter Arkh; 1998; 70(2):73-6. PubMed ID: 9551581
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
    Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy and diagnosis of intractable peptic ulcers].
    Ogoshi K; Kato T
    Nihon Naika Gakkai Zasshi; 1995 Jun; 84(6):873-8. PubMed ID: 7658117
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: synergy or null effect?
    Am J Manag Care; 2001 Sep; 7(12 Suppl):S402-3. PubMed ID: 11570032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.